Related Experiment Video

Updated: Jun 22, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Novel therapeutics for melanoma

Nagashree Seetharamu1, Patrick A Ott, Anna C Pavlick

  • 1NYU Cancer Institute, New York University Medical Center, New York, NY 10016, USA.

Expert Review of Anticancer Therapy
|June 6, 2009
PubMed

Insights

Advanced melanoma, a deadly skin cancer, has limited treatment options. New therapeutic agents are in development, offering hope for improved outcomes in this aggressive disease.

Area of Science:

  • Oncology
  • Dermatology
  • Immunology

Background:

  • Advanced melanoma presents a significant challenge due to its high mortality and low response rates to standard therapies like dacarbazine, temozolomide, and IL-2.
  • A deeper understanding of melanoma and cancer biology has spurred the development of novel therapeutic strategies.
  • The urgent need for effective treatments underscores the critical importance of identifying new active agents for advanced melanoma.

Purpose of the Study:

  • To review promising novel therapeutic agents currently in preclinical and clinical development for advanced melanoma.
  • To highlight advancements in understanding melanoma biology that inform new treatment approaches.

Main Methods:

  • Review of scientific literature and clinical trial data.
  • Analysis of preclinical and clinical development stages of novel therapeutic agents.
  • Discussion of emerging agents based on advances in cancer and immune biology.

Main Results:

  • Several novel therapeutic agents are under investigation for advanced melanoma.
  • Many of these agents are in various stages of preclinical and clinical trials.
  • Advances in understanding melanoma biology are yielding promising new treatment avenues.

Conclusions:

  • Novel therapeutics offer renewed hope for patients with advanced melanoma.
  • Continued research and clinical trials are essential to validate the efficacy of these new agents.
  • The development of targeted therapies represents a significant step forward in managing this aggressive cancer.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...